Trial Profile
Clinical Study for Safety and Efficacy of TSHR CART Cell in the Treatment of Refractory Thyroid Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2018
Price :
$35
*
At a glance
- Drugs Anti-TSHR-CAR-T-cell-therapy-Innovative-Cellular-Therapeutics (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 16 Aug 2018 New trial record